Prostate cancer (CaP) is the leading visceral malignancy in males.
Patients who undergo cardiac transplantation are immune compromised, thus presenting a therapeutic challenge. Immunosuppresion could accelerate tumor growth, while medical intervention may be associated with increased treatment mortality or morbidity. Due to paucity of such cases, there are no randomized trials that address the treatment algorithm for cardiac transplant patients with CaP, with only a few scattered reports in the literature. Treatment options range from hormonal manipulation to radiation therapy to radical prostatectomy. To our knowledge, we report the first successful robot-assisted laparoscopic radical prostatectomy in a heart transplant patient with CaP.
Written by:
Singh I, Patel BN, Thohan V, Hemal AK. Are you the author?
Department of Urology, Wake Forest University Medical Sciences and Baptist Medical Centre, Winston-Salem, NC, USA.
Reference: Urol Ann. 2013 Jan;5(1):56-8.
doi: 10.4103/0974-7796.106972
PubMed Abstract
PMID: 23662015
UroToday.com Prostate Cancer Section
